The goal of the IGNITE Awards program is to advance understanding of female-specific and sex-differentiated effects in novel therapeutics (drugs, devices, and digital diagnostics and therapeutics) for diseases that affect women exclusively, predominantly, or differentially. IGNITE investigations are important components of the Connors Center’s First.In.Women Precision Medicine Platform. This RFP is open to investigators with a primary appointment at Brigham and Women’s Hospital.
Amount: $50,000
Letter of Intent Deadline: October 14, 2020 — 12pm
Application Deadline (by invitation only): December 4, 2020 — 12pm
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
